469 related articles for article (PubMed ID: 12662153)
1. Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.
Basak A; Lazure C
Biochem J; 2003 Jul; 373(Pt 1):231-9. PubMed ID: 12662153
[TBL] [Abstract][Full Text] [Related]
2. Histidine-rich human salivary peptides are inhibitors of proprotein convertases furin and PC7 but act as substrates for PC1.
Basak A; Ernst B; Brewer D; Seidah NG; Munzer JS; Lazure C; Lajoie GA
J Pept Res; 1997 Jun; 49(6):596-603. PubMed ID: 9266488
[TBL] [Abstract][Full Text] [Related]
3. Enzymic characterization in vitro of recombinant proprotein convertase PC4.
Basak A; Touré BB; Lazure C; Mbikay M; Chrétien M; Seidah NG
Biochem J; 1999 Oct; 343 Pt 1(Pt 1):29-37. PubMed ID: 10493908
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases.
Van de Ven WJ; Roebroek AJ; Van Duijnhoven HL
Crit Rev Oncog; 1993; 4(2):115-36. PubMed ID: 8420571
[TBL] [Abstract][Full Text] [Related]
5. Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage.
Bergeron E; Basak A; Decroly E; Seidah NG
Biochem J; 2003 Jul; 373(Pt 2):475-84. PubMed ID: 12691605
[TBL] [Abstract][Full Text] [Related]
6. Barley serine proteinase inhibitor 2-derived cyclic peptides as potent and selective inhibitors of convertases PC1/3 and furin.
Villemure M; Fournier A; Gauthier D; Rabah N; Wilkes BC; Lazure C
Biochemistry; 2003 Aug; 42(32):9659-68. PubMed ID: 12911307
[TBL] [Abstract][Full Text] [Related]
7. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
Ballinger MD; Tom J; Wells JA
Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
[TBL] [Abstract][Full Text] [Related]
8. Proprotein convertase PC1/3-related peptides are potent slow tight-binding inhibitors of murine PC1/3 and Hfurin.
Boudreault A; Gauthier D; Lazure C
J Biol Chem; 1998 Nov; 273(47):31574-80. PubMed ID: 9813073
[TBL] [Abstract][Full Text] [Related]
9. The potent inhibitory activity of histone H1.2 C-terminal fragments on furin.
Han J; Zhang L; Shao X; Shi J; Chi C
FEBS J; 2006 Oct; 273(19):4459-69. PubMed ID: 16956366
[TBL] [Abstract][Full Text] [Related]
10. Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences.
Fugere M; Appel J; Houghten RA; Lindberg I; Day R
Mol Pharmacol; 2007 Jan; 71(1):323-32. PubMed ID: 17012622
[TBL] [Abstract][Full Text] [Related]
11. Peptidyl substrates containing unnatural amino acid at the P'1 position are potent inhibitors of prohormone convertases.
Basak A; Schmidt C; Ismail AA; Seidah NG; Chrétien M; Lazure C
Int J Pept Protein Res; 1995; 46(3-4):228-37. PubMed ID: 8537176
[TBL] [Abstract][Full Text] [Related]
12. Identification of inhibitors of prohormone convertases 1 and 2 using a peptide combinatorial library.
Apletalina E; Appel J; Lamango NS; Houghten RA; Lindberg I
J Biol Chem; 1998 Oct; 273(41):26589-95. PubMed ID: 9756897
[TBL] [Abstract][Full Text] [Related]
13. Evidence for proprotein convertase activity in the endoplasmic reticulum/early Golgi.
Salvas A; Benjannet S; Reudelhuber TL; Chrétien M; Seidah NG
FEBS Lett; 2005 Oct; 579(25):5621-5. PubMed ID: 16213495
[TBL] [Abstract][Full Text] [Related]
14. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.
Lissitzky JC; Luis J; Munzer JS; Benjannet S; Parat F; Chrétien M; Marvaldi J; Seidah NG
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):133-8. PubMed ID: 10657249
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel inhibitors of prohormone convertases.
Basak A; Jean F; Seidah NG; Lazure C
Int J Pept Protein Res; 1994 Sep; 44(3):253-61. PubMed ID: 7822102
[TBL] [Abstract][Full Text] [Related]
16. The prosegments of furin and PC7 as potent inhibitors of proprotein convertases. In vitro and ex vivo assessment of their efficacy and selectivity.
Zhong M; Munzer JS; Basak A; Benjannet S; Mowla SJ; Decroly E; Chrétien M; Seidah NG
J Biol Chem; 1999 Nov; 274(48):33913-20. PubMed ID: 10567353
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory activity and structural characterization of a C-terminal peptide fragment derived from the prosegment of the proprotein convertase PC7.
Bhattacharjya S; Xu P; Zhong M; Chrétien M; Seidah NG; Ni F
Biochemistry; 2000 Mar; 39(11):2868-77. PubMed ID: 10715106
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of convertase-related processing of proendothelin-1.
Denault JB; D'Orléans-Juste P; Masaki T; Leduc R
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S47-50. PubMed ID: 8587448
[TBL] [Abstract][Full Text] [Related]
19. Recombinant proprotein convertase 4 (PC4) from Leishmania tarentolae expression system: purification, biochemical study and inhibitor design.
Basak A; Shervani NJ; Mbikay M; Kolajova M
Protein Expr Purif; 2008 Aug; 60(2):117-26. PubMed ID: 18485734
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of the pro-peptide of subtilisin BPN'.
Cash PW; Zhu X; Ohta Y; Tsao J; Lackland H; Mateos-Nevado MD; Inouye M; Stein S; Jordan F; Tous GI
Pept Res; 1989; 2(4):292-6. PubMed ID: 2520768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
